跳转至内容
Merck
CN

HIGFMAG-52K

MILLIPLEX® Human IGF-I, II Panel

Configurable Human IGF-I, II 2-Plex Panel

登录 查看组织和合同定价。

关于此项目

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

MILLIPLEX® Human IGF-I, II Panel, Configurable Human IGF-I, II 2-Plex Panel

species reactivity

human

Quality Level

Gene Information

human ... IGF1(3479)

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 89%
(IGF-II)

sensitivity: 19 pg/mL
(MinDC+2SD; IGF-I)

sensitivity: 919 pg/mL
(MinDC+2SD; IGF-II)

standard curve range: 41-30,000 pg/mL
(IGF-I)

standard curve range: 892-650,000 pg/mL
(IGF-II)

inter-assay cv: <15%
intra-assay cv: <10%
(IGF-I)

inter-assay cv: <15%
intra-assay cv: <10%
(IGF-II)

technique(s)

multiplexing: suitable

input

cell culture supernatant
serum

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze IGF-1 and IGF-2 in human serum, plasma, or cell culture supernatants.Analytes included: IGF-1 and IGF-2Note: Sample extraction, using reagents included in the kit, is required for serum and plasma samples.Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Disclaimer

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Features and Benefits

Features:- Multiplex magnetic bead-based assay for simultaneous quantification of IGF-1 and IGF-2- Utilizes Luminex® xMAP® technology for high-throughput and reproducible results- Compatible with human serum, plasma, and tissue culture supernatants- High sensitivity and wide dynamic range for low-abundance detection- Includes all necessary reagents and standards for streamlined workflow- Verified for precision, reproducibility, and minimal cross-reactivityBenefits:- Enables focused analysis of IGF signaling in growth, metabolism, and disease- Reduces sample volume while maximizing data output- Saves time and cost compared to single-analyte ELISAs- Supports research in endocrine regulation, cancer progression, and aging- Provides reliable, reproducible data for both basic and translational research

General description

IGF-1 and IGF-2 are essential growth factors that regulate cell proliferation, differentiation, and survival. IGF-1 is a key mediator of growth hormone activity and plays a vital role in tissue development and repair, while IGF-2 is involved in fetal growth and has implications in cancer and metabolic disorders. Together, they provide valuable insights into endocrine function and growth-related pathologies.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Flam. Liq. 2 - Met. Corr. 1 - Skin Sens. 1

存储类别

3 - Flammable liquids

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Josep M Mercader et al.
Diabetes, 66(11), 2903-2914 (2017-08-26)
Type 2 diabetes (T2D) affects more than 415 million people worldwide, and its costs to the health care system continue to rise. To identify common or rare genetic variation with potential therapeutic implications for T2D, we analyzed and replicated genome-wide
Amanda L Ford et al.
Journal of the Academy of Nutrition and Dietetics, 120(4), 500-516 (2020-03-23)
Higher protein intakes may help reduce sarcopenia and facilitate recovery from illness and injury in older adults. However, high-protein diets (HPDs) including animal-sourced foods may negatively perturb the microbiota, and provision of probiotics and prebiotics may mitigate these effects. The
Effects of maternal obstructive sleep apnoea on fetal growth: a prospective cohort study.
Fung, AM; Wilson, DL; Lappas, M; Howard, M; Barnes, M; O'Donoghue, F; Tong, S; Esdale et al.
Testing null
Yili Zhang et al.
Journal of inflammation research, 15, 533-543 (2022-02-01)
To investigate the differences of several serum markers among population with different bone mass and to explore the utility of new potential biomarker for the diagnosing and screening for postmenopausal osteoporosis (PMOP). A total of 1055 postmenopausal women were screened
Kenneth Maleta et al.
The American journal of clinical nutrition, 113(2), 380-390 (2021-01-01)
Insulin-like growth factor I (IGF-I) is the most important hormonal promoter of linear growth in infants and young children. The objectives of this study were to compare plasma IGF-I concentration in a low- compared with a high-income country and characterize

相关内容

Multiplex immunoassays, such as MILLIPLEX® multiplex metabolic assays, are critical in metabolic syndrome research because they provide a full picture of the different conditions related to it, like diabetes and obesity, as well as save time and sample volume.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持